Publication | Closed Access

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease

HemodialysisHeart FailureRenal FunctionCardiovascular DiseaseKidney FailureChronic Kidney DiseasePharmacologyRenal ProtectionAcute Kidney InjuryMedicineNephrologyUnited Kingdom Heart